Altmetric

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

Title: Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Authors: Fendler, A
Shepherd, STC
Au, L
Wilkinson, KA
Wu, M
Schmitt, AM
Tippu, Z
Farag, S
Rogiers, A
Harvey, R
Carlyle, E
Edmonds, K
Del Rosario, L
Lingard, K
Mangwende, M
Holt, L
Ahmod, H
Korteweg, J
Foley, T
Barber, T
Emslie-Henry, A
Caulfield-Lynch, N
Byrne, F
Shum, B
Gerard, CL
Deng, D
Kjaer, S
Song, O-R
Queval, C
Kavanagh, C
Wall, EC
Carr, EJ
Namjou, S
Caidan, S
Gavrielides, M
MacRae, JI
Kelly, G
Peat, K
Kelly, D
Murra, A
Kelly, K
O'Flaherty, M
Shea, RL
Gardner, G
Murray, D
Yousaf, N
Jhanji, S
Van As, N
Young, K
Furness, AJS
Pickering, L
Beale, R
Swanton, C
Crick COVID19 consortium
Gandhi, S
Gamblin, S
Bauer, DLV
Kassiotis, G
Howell, M
Nicholson, E
Walker, S
Wilkinson, RJ
Larkin, J
Turajlic, S
CAPTURE consortium
Item Type: Journal Article
Issue Date: 29-Dec-2021
URI: http://hdl.handle.net/10044/1/93725
DOI: 10.1016/j.ccell.2021.12.013
Journal / Book Title: Cancer Cell
Copyright Statement: © 2021 Elsevier Inc.
Sponsor/Funder: Wellcome Trust
Funder's Grant Number: WDAI_P83556
Keywords: Oncology & Carcinogenesis
1109 Neurosciences
1112 Oncology and Carcinogenesis
Publication Status: Published online
Conference Place: United States
Open Access location: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716090/
Appears in Collections:Department of Infectious Diseases